• NORD’s Caregiver Respite Program Continues Through Pandemic
  • How I Get Through Bad Days With Friedreich’s Ataxia
  • FXN Gene Therapy Treats Heart Problems in New FA Mouse Model
  • Crawling Toward Fitness as My Abilities Change
  • The FA Community Needs Your Help to Advance a Potential Treatment
  • First In-human Trial of XCUR-FXN Planned for 2022
  • Remembering Keith Andrus, Who Left His Mark on the FA Community
  • Finding a Silver Lining in the Wake of 2020 and the Pandemic
  • NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum
  • My Loved Ones Perceive My Symptom Progression Differently
  • FA Research Alliance Petitioning for Urgent Access to Omaveloxolone
  • COVID-19 Vaccines Bring Relief for Many, Envy for Some